×
About 6,155 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  2,781 results

Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review a...
https://doi.org/10.1111/ijd.15671
International Journal of Dermatology; Gotesman RD, Choi C et. al.

Jun 2nd, 2021 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that presents with recurrent inflammatory nodules and draining tunnels in the skin. Most HS studies have focused on Western populations, and the understanding of how HS charact...

Squamous cell carcinoma arising within hidradenitis suppurativa: a literature review.
https://doi.org/10.1111/ijd.15677
International Journal of Dermatology; Sachdeva M, Mufti A et. al.

Jun 2nd, 2021 - Squamous cell carcinoma (SCC) can present as a rare complication of longstanding hidradenitis suppurativa (HS) lesions. Limited data exist on characteristics and outcomes of SCC development within HS lesions. The purpose of this review is to condu...

Psychosocial Impact of Hidradenitis Suppurativa: A Practical Guide for Clinicians.
https://doi.org/10.1080/09546634.2021.1937483
The Journal of Dermatological Treatment; Weigelt MA, Milrad SF et. al.

Jun 1st, 2021 - Introduction Hidradenitis Suppurativa (HS) is a debilitating skin disease with significant and often underappreciated effects on quality of life; available treatments fail to achieve consistent rates of remission. Targeting the psychosocial impact...

NOD2 signalling in hidradenitis suppurativa.
https://doi.org/10.1111/ced.14773
Clinical and Experimental Dermatology; Gambichler T, Hessam S et. al.

May 31st, 2021 - Hidradenitis suppurativa (HS) is associated with dysregulated immune responses including altered expression of cytokines, chemokines, and antimicrobial peptides and proteins (AMPs). To evaluate the expression of NOD2 and related factors in HS skin...

Seasonal Burden of National Emergency Department Visits due to Hidradenitis Suppurativa.
https://doi.org/10.1016/j.jaad.2021.05.023
Journal of the American Academy of Dermatology; Tripathi R, Korman NJ et. al.

May 29th, 2021 - Seasonal Burden of National Emergency Department Visits due to Hidradenitis Suppurativa.|2021|Tripathi R,Korman NJ,Ezaldein HH,|

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Clinicaltrials.gov  3,009 results

Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review a...
https://doi.org/10.1111/ijd.15671
International Journal of Dermatology; Gotesman RD, Choi C et. al.

Jun 2nd, 2021 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that presents with recurrent inflammatory nodules and draining tunnels in the skin. Most HS studies have focused on Western populations, and the understanding of how HS charact...

Squamous cell carcinoma arising within hidradenitis suppurativa: a literature review.
https://doi.org/10.1111/ijd.15677
International Journal of Dermatology; Sachdeva M, Mufti A et. al.

Jun 2nd, 2021 - Squamous cell carcinoma (SCC) can present as a rare complication of longstanding hidradenitis suppurativa (HS) lesions. Limited data exist on characteristics and outcomes of SCC development within HS lesions. The purpose of this review is to condu...

Psychosocial Impact of Hidradenitis Suppurativa: A Practical Guide for Clinicians.
https://doi.org/10.1080/09546634.2021.1937483
The Journal of Dermatological Treatment; Weigelt MA, Milrad SF et. al.

Jun 1st, 2021 - Introduction Hidradenitis Suppurativa (HS) is a debilitating skin disease with significant and often underappreciated effects on quality of life; available treatments fail to achieve consistent rates of remission. Targeting the psychosocial impact...

NOD2 signalling in hidradenitis suppurativa.
https://doi.org/10.1111/ced.14773
Clinical and Experimental Dermatology; Gambichler T, Hessam S et. al.

May 31st, 2021 - Hidradenitis suppurativa (HS) is associated with dysregulated immune responses including altered expression of cytokines, chemokines, and antimicrobial peptides and proteins (AMPs). To evaluate the expression of NOD2 and related factors in HS skin...

Seasonal Burden of National Emergency Department Visits due to Hidradenitis Suppurativa.
https://doi.org/10.1016/j.jaad.2021.05.023
Journal of the American Academy of Dermatology; Tripathi R, Korman NJ et. al.

May 29th, 2021 - Seasonal Burden of National Emergency Department Visits due to Hidradenitis Suppurativa.|2021|Tripathi R,Korman NJ,Ezaldein HH,|

see more →

News  271 results

Two Studies Add to Knowledge Base of Biosimilar Use in Psoriasis, HS
https://www.medscape.com/viewarticle/950197

Apr 28th, 2021 - A cohort study of psoriasis patients in Denmark found that a nonmedical switch from brand name adalimumab to adalimumab biosimilars was not associated with drug retention at 1 year. And another study, a small, single-center retrospective study of ...

New Analysis Eyes the Surgical Landscape for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/948026

Mar 23rd, 2021 - Among patients who undergo surgery for hidradenitis suppurativa (HS), wide excision and flap-based reconstruction are associated with lower postsurgical recurrence, yet these options should be balanced against potentially higher morbidity of exten...

Inflammatory Skin Diseases and CKD Risk: What’s the Link?
https://www.medscape.com/viewarticle/947916

Mar 22nd, 2021 - Takeaway Atopic eczema, psoriasis and hidradenitis suppurativa were weakly associated with chronic kidney disease (CKD), independent of obesity, cardiovascular morbidity or non-biologic nephrotoxic skin medications. No evidence supporting this ass...

Adalimumab Enhances Primary Wound Closure After HS Surgery
https://www.medscape.com/viewarticle/945207

Feb 2nd, 2021 - Delaying surgical reconstruction of fistula structures until after patients with hidradenitis suppurativa (HS) have been on adalimumab for a minimum of 6 months transforms primary wound closure into a highly attractive option, a pilot study sugges...

Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/944781

Jan 26th, 2021 - A once-daily oral selective Janus kinase 1 inhibitor demonstrated promising safety and efficacy for the treatment of moderate to severe hidradenitis suppurativa (HS) in a pair of small, randomized, phase 2 studies that established proof-of-concept...

see more →

Patient Education  93 results see all →